tiprankstipranks
Advertisement
Advertisement
BridgeBio Oncology initiated with a Buy at Canaccord
PremiumThe FlyBridgeBio Oncology initiated with a Buy at Canaccord
2M ago
BridgeBio Oncology initiated with a Buy at Canaccord
Premium
The Fly
BridgeBio Oncology initiated with a Buy at Canaccord
2M ago
Analyst Reiterates Buy on BridgeBio Oncology Therapeutics with Unchanged $29 12-Month Price Target Amid Promising Pan-KRAS Pipeline
Premium
Ratings
Analyst Reiterates Buy on BridgeBio Oncology Therapeutics with Unchanged $29 12-Month Price Target Amid Promising Pan-KRAS Pipeline
2M ago
BridgeBio Oncology’s Narrow Bet on KRAS and PI3K Programs Raises Concentration Risk, Limits Strategic Flexibility
PremiumCompany AnnouncementsBridgeBio Oncology’s Narrow Bet on KRAS and PI3K Programs Raises Concentration Risk, Limits Strategic Flexibility
4M ago
BridgeBio Oncology announces publication of preclinical data on BBO-11818
Premium
The Fly
BridgeBio Oncology announces publication of preclinical data on BBO-11818
4M ago
BridgeBio Oncology price target raised to $29 from $27 at H.C. Wainwright
Premium
The Fly
BridgeBio Oncology price target raised to $29 from $27 at H.C. Wainwright
4M ago
BridgeBio Oncology reports promising RAS and PI3Kα data
PremiumCompany AnnouncementsBridgeBio Oncology reports promising RAS and PI3Kα data
6M ago
BridgeBio Oncology announces new clinical data across 3 pipeline programs
Premium
The Fly
BridgeBio Oncology announces new clinical data across 3 pipeline programs
6M ago
BridgeBio Oncology initiated with an Overweight at Morgan Stanley
Premium
The Fly
BridgeBio Oncology initiated with an Overweight at Morgan Stanley
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100